Journal of Dermatitis

Gabbia Biotechnology, Itajaí, Santa Catarina, Brazil

Publications

• Research Article   
  Safety and Effectiveness of Inactivated Streptococcus thermophilus Atcc 19258 (Neoimmuno Hilus Gb®) Lotion on Atopic Dermatitis: A Randomized Placebo-Controlled Clinical Trial
  Author(s): Marina Piola Rossetto, Gabriel Fernandes Alves Jesus, Ana Paula Voytena, Silvia Dal-Bó, Zoé Feuser, Heloisa de Medeiros Borges and Monique Michels*
  
  Aim: Our aim was evaluated the safety and clinical efficacy of a posbiotic lotion in the treatment of atopic dermatitis. Methods: Randomized, double-blind, placebo-controlled clinical trial was performed in patients who had any degree of atopic dermatitis. A total of 24 volunteers were recruited and randomly divided into two groups: Placebo or Treated. (1% NEOIMUNO HILUS GB®). The ingredient used was NEOIMUNO HILUS GB® (Streptococcus thermophilus strain ATCC 19258). Physical analysis to determine the dermatitis degree and perception questionnaire was applied before and after treatment. The questionnaire included questions about perception of itching, oiliness, humidity and product quality. Statistical analyses were performed. Results: The volunteers in the Treated Group showed a significant improve.. View more»
  

  DOI: 10.35248/2684-1436.23.8.202

  Abstract HTML PDF